BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,050 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $261,000 | +1.2% | 3,036 | -5.5% | 0.08% | -10.2% |
Q3 2021 | $258,000 | -0.4% | 3,212 | 0.0% | 0.09% | -2.2% |
Q2 2021 | $259,000 | -7.2% | 3,212 | -3.0% | 0.09% | -17.4% |
Q1 2021 | $279,000 | +13.4% | 3,312 | +8.2% | 0.11% | +7.9% |
Q4 2020 | $246,000 | -37.6% | 3,062 | -4.7% | 0.10% | -45.4% |
Q3 2020 | $394,000 | +42.2% | 3,212 | 0.0% | 0.18% | +22.5% |
Q2 2020 | $277,000 | +4.9% | 3,212 | -1.4% | 0.15% | -14.2% |
Q1 2020 | $264,000 | -1.9% | 3,257 | +1.4% | 0.18% | +6.0% |
Q4 2019 | $269,000 | -25.3% | 3,212 | -21.9% | 0.17% | +1.8% |
Q3 2019 | $360,000 | +5.0% | 4,112 | -1.8% | 0.16% | -25.9% |
Q2 2019 | $343,000 | +4.6% | 4,187 | -0.7% | 0.22% | -5.6% |
Q1 2019 | $328,000 | +18.4% | 4,215 | 0.0% | 0.23% | +1.3% |
Q4 2018 | $277,000 | -15.8% | 4,215 | -1.2% | 0.23% | -5.7% |
Q3 2018 | $329,000 | +4.4% | 4,265 | 0.0% | 0.24% | +10.9% |
Q2 2018 | $315,000 | +13.7% | 4,265 | 0.0% | 0.22% | +6.3% |
Q1 2018 | $277,000 | +0.4% | 4,265 | 0.0% | 0.21% | -1.9% |
Q4 2017 | $276,000 | +3.0% | 4,265 | 0.0% | 0.21% | -3.7% |
Q3 2017 | $268,000 | -8.2% | 4,265 | -11.6% | 0.22% | -10.6% |
Q2 2017 | $292,000 | +32.1% | 4,823 | +13.1% | 0.24% | +67.8% |
Q1 2017 | $221,000 | +16.9% | 4,265 | 0.0% | 0.15% | +16.8% |
Q4 2016 | $189,000 | – | 4,265 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |